巴氏皮查和免疫增强药物治疗溃疡性结肠炎的疗效

Pooja Sharma, D. Kajaria
{"title":"巴氏皮查和免疫增强药物治疗溃疡性结肠炎的疗效","authors":"Pooja Sharma, D. Kajaria","doi":"10.4103/ijaim.ijaim_6_22","DOIUrl":null,"url":null,"abstract":"Ulcerative colitis (UC) is an immune-mediated disease; the intestine contains an enormous colitis antigenic load derived from the food and microbial flora. There appear to be four main factors which influence the disease: host genetic susceptibility, a dysregulated immune response, impairment of intestinal epithelial barrier function, and environmental factors. According to Ayurveda, it may be correlated with Raktatisara, which is mentioned as advanced stages of Pittatisara with similar signs and symptoms. A 19-year-old female patient was diagnosed with UC in May 2018, with the complaints of frequent defecation of stool mixed with blood and pain in the abdomen. She consulted allopathic physician and where the patient was diagnosed with UC through sigmoidoscopy, colonoscopy, and biopsy. The patient was on conservative treatment for 2 months. The patient gradually developed the following symptoms like bilateral pain in all major and minor joints, hair loss, reddish discoloration on both medial aspect of thigh and hips. After getting no relief, the patient visited outpatient department of AllA, Sarita Vihar, New Delhi. The patient was admitted to the inpatient department of AIIA hospital. After the 41 days of treatment, stool examination shows no occult blood in stool, followed by 2 months follow-up and the patient got 80% relief in all the signs and symptoms. Piccha Basti along with oral medicines is highly effective in the management of Raktatisara. This case report highlights the efficacy of Piccha basti and immune enhancer medicines in the management of UC and provide a better pathway for this disease.","PeriodicalId":168535,"journal":{"name":"INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU","volume":"155 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of Piccha Basti and immune enhancer medicines in the management of ulcerative colitis\",\"authors\":\"Pooja Sharma, D. Kajaria\",\"doi\":\"10.4103/ijaim.ijaim_6_22\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ulcerative colitis (UC) is an immune-mediated disease; the intestine contains an enormous colitis antigenic load derived from the food and microbial flora. There appear to be four main factors which influence the disease: host genetic susceptibility, a dysregulated immune response, impairment of intestinal epithelial barrier function, and environmental factors. According to Ayurveda, it may be correlated with Raktatisara, which is mentioned as advanced stages of Pittatisara with similar signs and symptoms. A 19-year-old female patient was diagnosed with UC in May 2018, with the complaints of frequent defecation of stool mixed with blood and pain in the abdomen. She consulted allopathic physician and where the patient was diagnosed with UC through sigmoidoscopy, colonoscopy, and biopsy. The patient was on conservative treatment for 2 months. The patient gradually developed the following symptoms like bilateral pain in all major and minor joints, hair loss, reddish discoloration on both medial aspect of thigh and hips. After getting no relief, the patient visited outpatient department of AllA, Sarita Vihar, New Delhi. The patient was admitted to the inpatient department of AIIA hospital. After the 41 days of treatment, stool examination shows no occult blood in stool, followed by 2 months follow-up and the patient got 80% relief in all the signs and symptoms. Piccha Basti along with oral medicines is highly effective in the management of Raktatisara. This case report highlights the efficacy of Piccha basti and immune enhancer medicines in the management of UC and provide a better pathway for this disease.\",\"PeriodicalId\":168535,\"journal\":{\"name\":\"INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU\",\"volume\":\"155 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4103/ijaim.ijaim_6_22\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"INDIAN JOURNAL OF AYURVEDA & INTEGRATIVE MEDICINE KLEU","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijaim.ijaim_6_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

溃疡性结肠炎(UC)是一种免疫介导疾病;肠道含有来自食物和微生物菌群的大量结肠炎抗原负荷。影响该病的主要因素有四个:宿主遗传易感性、免疫反应失调、肠上皮屏障功能受损和环境因素。根据阿育吠陀的说法,它可能与raktatisra有关,raktatisra被认为是pittatisra的晚期,具有类似的体征和症状。一名19岁女性患者于2018年5月被诊断为UC,主诉为频繁排便混血,腹部疼痛。她咨询了对症医生,并通过乙状结肠镜检查、结肠镜检查和活检诊断为UC。保守治疗2个月。患者逐渐出现以下症状:双侧各大、小关节疼痛,脱发,大腿和臀部内侧发红。在没有得到缓解后,患者去了新德里Sarita Vihar的真主安拉门诊部。病人被收住在AIIA医院住院部。治疗41 d后大便检查未见大便隐血,随访2个月,患者各项体征症状缓解80%。Piccha Basti和口服药物在治疗Raktatisara方面非常有效。本病例报告强调了底Piccha和免疫增强药物在UC治疗中的疗效,并为这种疾病提供了更好的途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Efficacy of Piccha Basti and immune enhancer medicines in the management of ulcerative colitis
Ulcerative colitis (UC) is an immune-mediated disease; the intestine contains an enormous colitis antigenic load derived from the food and microbial flora. There appear to be four main factors which influence the disease: host genetic susceptibility, a dysregulated immune response, impairment of intestinal epithelial barrier function, and environmental factors. According to Ayurveda, it may be correlated with Raktatisara, which is mentioned as advanced stages of Pittatisara with similar signs and symptoms. A 19-year-old female patient was diagnosed with UC in May 2018, with the complaints of frequent defecation of stool mixed with blood and pain in the abdomen. She consulted allopathic physician and where the patient was diagnosed with UC through sigmoidoscopy, colonoscopy, and biopsy. The patient was on conservative treatment for 2 months. The patient gradually developed the following symptoms like bilateral pain in all major and minor joints, hair loss, reddish discoloration on both medial aspect of thigh and hips. After getting no relief, the patient visited outpatient department of AllA, Sarita Vihar, New Delhi. The patient was admitted to the inpatient department of AIIA hospital. After the 41 days of treatment, stool examination shows no occult blood in stool, followed by 2 months follow-up and the patient got 80% relief in all the signs and symptoms. Piccha Basti along with oral medicines is highly effective in the management of Raktatisara. This case report highlights the efficacy of Piccha basti and immune enhancer medicines in the management of UC and provide a better pathway for this disease.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信